- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Aqueous humor.
Displaying page 1 of 1.
| EudraCT Number: 2006-001156-12 | Sponsor Protocol Number: 73652 | Start Date*: 2006-04-04 | |||||||||||
| Sponsor Name:Santen Oy | |||||||||||||
| Full Title: Corneal penetration of timolol into the human aqueous humor after administration of 0.1% Timosan eye gel or 0.5% timolol eye drops | |||||||||||||
| Medical condition: Pharmacokinetic study of glaucoma drug in cataract patients | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FI (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2022-003825-24 | Sponsor Protocol Number: 2059/2022 | Start Date*: 2024-03-15 |
| Sponsor Name:Medical University of Vienna | ||
| Full Title: Drug Concentration and degradation profiles of steroid and antibiotic eye drops in human aqueous humor. | ||
| Medical condition: Postoperative inflammatory response - pharmakokinetics of steroids and antibiotics applied as eye drops | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-004336-20 | Sponsor Protocol Number: LT1225-PII-04/08 | Start Date*: 2008-11-28 |
| Sponsor Name:Laboratoires Thea | ||
| Full Title: Azithromycin concentration into aqueous humor of patients undergoing cataract surgery, after 3 days of treatment by AZYTER ® Open randomised monocentre study with 2 groups of 15 patients | ||
| Medical condition: Patient concerned by this trial are patients who will undergo a cataract surgery | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-001389-18 | Sponsor Protocol Number: 1 | Start Date*: 2006-09-27 |
| Sponsor Name:Ludwig Boltzmann Institute forRetinology and Biomicroscopic Laser Surgery | ||
| Full Title: Comparison of Combined Therapy of Intravitreal Injection of Bevacizumab and Pegaptanib versus Mono-therapy (The MAAM Study) | ||
| Medical condition: Subjects of either gender aged > 50 years, diagnosed with subfoveal CNV secondary to AMD, a predominantly occult lesion composition, and with best corrected visual acuity of 20/40 to 20/200 in the ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-001149-15 | Sponsor Protocol Number: LevoDesa_05-2017 | Start Date*: 2018-07-31 | |||||||||||
| Sponsor Name:NTC SRL | |||||||||||||
| Full Title: Aqueous humour concentrations after topical apPlication of combinEd levofloxacin dexamethasone eye dRops and of its single components: a randoMized, assEssor-blinded, parallel-group study in patien... | |||||||||||||
| Medical condition: Patients for which cataract surgery has been planned. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-005700-24 | Sponsor Protocol Number: SC | Start Date*: 2015-08-17 | |||||||||||
| Sponsor Name:Abteilung für Augenheilkunde, AKH Linz | |||||||||||||
| Full Title: Aqueous Humor cytokine Levels following intravitreal ranibizumab or dexamethasone therapy in patients with diabetic macular edema | |||||||||||||
| Medical condition: Diabetic Retinopathy and diabetic macular edema are leading causes for visual loss and blindness in young adults around the world. | |||||||||||||
|
|||||||||||||
| Population Age: Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2017-003193-14 | Sponsor Protocol Number: DIAMOND | Start Date*: 2017-10-03 |
| Sponsor Name:Department of Ophthalmology, MUW | ||
| Full Title: Disease-modification under treatment with aflibercept in advanced diabetic retinopathy - A pilot study | ||
| Medical condition: proliferative diabetic retinopathy | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-001174-30 | Sponsor Protocol Number: MR41926 | Start Date*: 2021-03-11 | |||||||||||
| Sponsor Name:F.Hoffman-La Roche Ltd. | |||||||||||||
| Full Title: AN EXPLORATORY, PROSPECTIVE, MULTI-CENTER, OPEN-LABEL, SINGLE-ARM, INTERVENTIONAL, PHASE IIB STUDY TO INVESTIGATE AQUEOUS HUMOR AND MULTIMODAL IMAGING BIOMARKERS IN TREATMENT-NAÏVE PATIENTS WITH DI... | |||||||||||||
| Medical condition: Diabetic Macular Edema, a complication of Diabetic Retinopathy | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) PL (Completed) IT (Completed) HR (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-003515-10 | Sponsor Protocol Number: BP41783 | Start Date*: 2021-03-09 | |||||||||||
| Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
| Full Title: A LONGITUDINAL, BIOMARKER STUDY OF ANTI-VEGF, TO EXPLORE THE RELATIONSHIP BETWEEN AQUEOUS HUMOR COMPOSITION AND MULTIMODAL RETINAL IMAGING IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND DIABET... | |||||||||||||
| Medical condition: Treatment Naïve Neovascular Age-Related Macular Degeneration (nAMD) and Treatment Naïve diabetic macular edema (DME) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: CZ (Completed) PL (Completed) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2016-001060-11 | Sponsor Protocol Number: FSJD-RTB-2015 | Start Date*: 2017-08-03 | |||||||||||
| Sponsor Name:Fundació Sant Joan de Déu | |||||||||||||
| Full Title: A Phase I, unicentric, open and dose escalation clinical trial to evaluate the safety and the activity of the oncolytic adenovirus VCN-01 in patients with refractory retinoblastoma | |||||||||||||
| Medical condition: Refractory Retinoblastoma | |||||||||||||
|
|||||||||||||
| Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.